| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Cybin Inc. | Psilocybin - (EMBARK) | Mental distress in healthcare workers | Phase 2 | Trial Planned | Oral | Psychiatric |
| Cyclerion Therapeutics Inc. | Praliciguat (IW-1973) | Heart failure HFpEF | Phase 2 | Oral | Cardiology | |
| Cyclerion Therapeutics Inc. | Olinciguat - STRONG-SCD | Sickle Cell disease | Phase 2 | Oral | Hematology | |
| Cyclo Therapeutics Inc. | AMT-101 - (CASTRO) | Rheumatoid arthritis | Phase 2 | Ongoing | oral | Immunology: Anti-TNF |
| Cyclo Therapeutics Inc. | AMT-101 combo with with anti-TNFα - (MARKET) | Ulcerative colitis | Phase 2 | Trial Completed | Oral | Gastroenterology |
| Cyclo Therapeutics Inc. | AMT-101 - (FILLMORE) | Pouchitis | Phase 2 | Ongoing | Oral | Gastroenterology |
| Cyclo Therapeutics Inc. | Trappsol Cyclo | Alzheimer’s Disease | Phase 2b | Ongoing | Intravenous | Neurology |
| Cyclo Therapeutics Inc. | Trappsol Cyclo - (TransportNPC) | Niemann-Pick Disease Type C | Phase 3 | Ongoing | Intravenous | Genetic Disorder |